BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12581383)

  • 1. Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis.
    Logullo AF; Nonogaki S; Miguel RE; Kowalski LP; Nishimoto IN; Pasini FS; Federico MH; Brentani RR; Brentani MM
    J Oral Pathol Med; 2003 Mar; 32(3):139-45. PubMed ID: 12581383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx.
    Kojc N; Zidar N; Vodopivec B; Gale N
    Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa.
    Pasini FS; Brentani MM; Kowalski LP; Federico MH
    Head Neck; 2001 Sep; 23(9):725-32. PubMed ID: 11505481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of transforming growth factor beta1 and its receptors in normal human urothelium and human transitional cell carcinomas.
    Izadifar V; de Boer WI; Muscatelli-Groux B; Maillé P; van der Kwast TH; Chopin DK
    Hum Pathol; 1999 Apr; 30(4):372-7. PubMed ID: 10208456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
    Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
    Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
    Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
    J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients.
    Mangone FR; Walder F; Maistro S; Pasini FS; Lehn CN; Carvalho MB; Brentani MM; Snitcovsky I; Federico MH
    Mol Cancer; 2010 May; 9():106. PubMed ID: 20462450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
    Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
    Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.
    Wang J; Han W; Zborowska E; Liang J; Wang X; Willson JK; Sun L; Brattain MG
    J Biol Chem; 1996 Jul; 271(29):17366-71. PubMed ID: 8663343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta receptors in verrucous and squamous cell carcinoma.
    Anderson M; Muro-Cacho C; Cordero J; Livingston S; Muñoz-Antonia T
    Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):849-54. PubMed ID: 10448730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
    Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
    Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of transforming growth factor beta1, transforming growth factor type I and II receptors, and TNF-alpha in the mucosa of the small intestine in infants with food protein-induced enterocolitis syndrome.
    Chung HL; Hwang JB; Park JJ; Kim SG
    J Allergy Clin Immunol; 2002 Jan; 109(1):150-4. PubMed ID: 11799382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implication of ERCC1 protein expression in resected oropharynx and oral cavity cancer.
    An HJ; Jo H; Jung CK; Kang JH; Kim MS; Sun DI; Cho KJ; Cho JH; Won HS; Sun S; Ko YH
    Pathol Res Pract; 2017 Aug; 213(8):949-955. PubMed ID: 28645807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.
    de Koning PJ; Bovenschen N; Leusink FK; Broekhuizen R; Quadir R; van Gemert JT; Hordijk GJ; Chang WS; van der Tweel I; Tilanus MG; Kummer JA
    Int J Cancer; 2009 Oct; 125(7):1542-50. PubMed ID: 19569240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP-2 expression correlates with local failure in head and neck squamous cell carcinoma.
    Sand JP; Kokorina NA; Zakharkin SO; Lewis JS; Nussenbaum B
    Otolaryngol Head Neck Surg; 2014 Feb; 150(2):245-50. PubMed ID: 24247005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma.
    Mineta H; Ogino T; Amano HM; Ohkawa Y; Araki K; Takebayashi S; Miura K
    Anticancer Res; 1998; 18(6B):4765-8. PubMed ID: 9891554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
    Gootee J; Patel M; Aurit S; Silberstein P
    Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
    Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R
    Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers.
    Jude EB; Blakytny R; Bulmer J; Boulton AJ; Ferguson MW
    Diabet Med; 2002 Jun; 19(6):440-7. PubMed ID: 12060054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.